
Shree Pacetronix Sees Unprecedented Buying Interest, Edges Towards Multi-Day Upper Circuit
2025-12-04 10:35:37Shree Pacetronix Ltd, a key player in the Healthcare Services sector, has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and an order book filled exclusively with buy orders. This rare market phenomenon signals robust investor enthusiasm and raises the prospect of a sustained multi-day circuit scenario.
Read More
Shree Pacetronix Sees Extraordinary Buying Interest Amid Upper Circuit Lock
2025-12-03 13:20:22Shree Pacetronix Ltd has attracted remarkable buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This unusual market activity signals strong investor confidence and the potential for a sustained multi-day circuit scenario.
Read More
Shree Pacetronix Faces Intense Selling Pressure Amid Consecutive Losses
2025-12-02 10:30:28Shree Pacetronix Ltd is experiencing significant selling pressure, with the stock hitting a lower circuit and an absence of buyers on the trading day. The healthcare services company’s shares have recorded consecutive losses, underperforming both its sector and the broader market indices, signalling distress selling and heightened market caution.
Read More
Shree Pacetronix Faces Intense Selling Pressure Amid Consecutive Losses
2025-12-01 11:20:27Shree Pacetronix Ltd has encountered significant selling pressure on 1 December 2025, with the stock registering a decline of 1.85% and exhibiting a rare scenario of exclusively sell orders in the queue. This distress selling signals heightened investor caution as the stock continues a nine-day losing streak, contrasting sharply with the broader market's modest gains.
Read More
Shree Pacetronix Faces Intense Selling Pressure Amid Consecutive Losses
2025-11-28 11:25:20Shree Pacetronix Ltd is currently experiencing significant selling pressure, with the stock hitting a lower circuit and exhibiting a complete absence of buyers. The healthcare services company has recorded a continuous decline over the past eight trading sessions, signalling distress selling and heightened market caution.
Read More
Shree Pacetronix Faces Intense Selling Pressure Amid Consecutive Losses
2025-11-27 11:30:17Shree Pacetronix Ltd has encountered significant selling pressure, with the stock registering a continuous decline over the past week and no buyers present in the market today. The healthcare services company’s shares have been locked at the lower circuit, reflecting distress selling and a lack of demand amid a challenging trading session.
Read More
Shree Pacetronix Faces Intense Selling Pressure Amid Consecutive Declines
2025-11-26 10:40:27Shree Pacetronix Ltd has encountered significant selling pressure today, with the stock registering a lower circuit and an absence of buyers in the queue. The healthcare services company has recorded a continuous decline over the past six trading sessions, signalling distress selling and heightened market caution.
Read More
Shree Pacetronix Faces Intense Selling Pressure Amid Consecutive Losses
2025-11-25 11:35:24Shree Pacetronix Ltd has encountered significant selling pressure in recent sessions, with the stock registering a continuous decline over the past five days. The absence of buyers today has resulted in a lower circuit scenario, signalling distress selling within the Healthcare Services sector.
Read MoreIs Shree Pacetronix overvalued or undervalued?
2025-11-25 08:10:02Understanding Shree Pacetronix’s Valuation Metrics At a current price of ₹251.70, Shree Pacetronix trades with a price-to-earnings (PE) ratio of approximately 42.5, which on the surface appears elevated compared to traditional benchmarks. However, this figure must be contextualised within the company’s strong operational performance and growth prospects. The price-to-book value stands at 6.23, reflecting investor confidence in the company’s asset utilisation and future earnings potential. More telling are the enterprise value multiples: EV to EBIT at 28.82 and EV to EBITDA at 23.84. These ratios, while higher than some peers, are justified by Shree Pacetronix’s impressive return on capital employed (ROCE) of 18.04% and return on equity (ROE) of 14.66%. Such returns ind...
Read MoreIntimation Of Receipt Of Trading Approval For 75150 Equity Shares Of Rs.10/- Each Issued At Premium Of Rs. 71/- Bearing Distinctive Numbers From 3599401 To 3674550 Issued To Promoter On A Preferential Basis
22-Jan-2026 | Source : BSEPursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015 we wish to inform that BSE Limited vide their letter(s) dated Wednesday January 21 2026 having reference no. LOD/PREF/PB/249/2025-2026 have granted trading approval for the trading of 75150 equity shares of Rs. 10/- each at an issue price of Rs. 81/- per share allotted to the promoter on a preferential basis. The approval letter received from the Stock Exchange i.e. BSE Limited is enclosed herewith.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
13-Jan-2026 | Source : BSEIn accordance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulation 2018 please find enclosed herewith the certificate received from the Registrar and Share Transfer Agent of the Company M/s Ankit Consultancy Pvt. Ltd. for the quarter ended 31st December 2025. You are requested to please take on record the above said document for your reference & further needful.
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
07-Jan-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dheeraj Kumar Lohia & PACs
Corporate Actions
No Upcoming Board Meetings
Shree Pacetronix Ltd has declared 5% dividend, ex-date: 24 Sep 07
No Splits history available
No Bonus history available
No Rights history available